Hetero-bivalent agents targeting FAP and PSMA
Srikanth Boinapally(Johns Hopkins University), Sangeeta Ray Banerjee(Techno India University), Gabriela Lofland(Morgan State University), Cory Brayton(Cornell University), Min Jay Shin(Morgan State University), Zirui Jiang(Morgan State University), Martin G. Pomper(Southwestern Medical Center), Lei Zheng(Southern Medical University), Vanessa F. Merino(University of Maryland, Baltimore), Alla Lisok(Morgan State University), Yu Yan(Johns Hopkins University), Il Minn(Southwestern Medical Center)
Cited by 45
Related Papers
Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
|Cancer Cell|2012|652
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
|Biochemical and Biophysical Research Communications|2004|350
Amide proton transfer imaging of human brain tumors at 3T
|Magnetic Resonance in Medicine|2006|341
Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.
|The Journal of Cell Biology|1989|221
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209